Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinblastine vs Hydroxyurea in AML with Hyperleukocytosis
NCT05062278Phase 2Recruiting
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Jul 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinblastine in acute myeloid leukemia (AML), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Jul 2021; status: recruiting.
02
Drugs
vinblastine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT05062278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05062278.